BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Barrera B, Otero JA, Egido E, Prieto JG, Seelig A, Álvarez AI, Merino G. The anthelmintic triclabendazole and its metabolites inhibit the membrane transporter ABCG2/BCRP. Antimicrob Agents Chemother 2012;56:3535-43. [PMID: 22508302 DOI: 10.1128/AAC.06345-11] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Blanco-Paniagua E, Álvarez-Fernández L, Garcia-Lino AM, Álvarez AI, Merino G. Secretion into Milk of the Main Metabolites of the Anthelmintic Albendazole Is Mediated by the ABCG2/BCRP Transporter. Antimicrob Agents Chemother 2022;66:e0006222. [PMID: 35736132 DOI: 10.1128/aac.00062-22] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Yan L, Liu Y, Ma XF, Hou D, Zhang YH, Sun Y, Shi SS, Forouzanfar T, Lin HY, Fan J, Wu G. Triclabendazole Induces Pyroptosis by Activating Caspase-3 to Cleave GSDME in Breast Cancer Cells. Front Pharmacol 2021;12:670081. [PMID: 34305590 DOI: 10.3389/fphar.2021.670081] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
3 Khattab M. Theoretical study of the geometric and electronic characterization of carbendazim-based drug (Nocodazole). Heliyon 2020;6:e04055. [PMID: 32548318 DOI: 10.1016/j.heliyon.2020.e04055] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
4 Farczadi L, Vlase L, Melles O, Tolomeiu R, Tamas-krumpe O, Buta A, Ognean L. The Statistical Analysis of Pharmacokinetic Parameters in the Context of Bioequivalence Testing of Two Anthelmintic Formulas Based on Ivermectine and Triclabendazole in Sheep. Acta Medica Marisiensis 2019;65:60-5. [DOI: 10.2478/amma-2019-0015] [Reference Citation Analysis]
5 Giri P, Gupta L, Naidu S, Joshi V, Patel N, Giri S, Srinivas NR. In Vitro Drug-Drug Interaction Potential of Sulfoxide and/or Sulfone Metabolites of Albendazole, Triclabendazole , Aldicarb, Methiocarb, Montelukast and Ziprasidone. Drug Metab Lett 2018;12:101-16. [PMID: 30117405 DOI: 10.2174/1872312812666180816164626] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
6 Siles-Lucas M, Casulli A, Cirilli R, Carmena D. Progress in the pharmacological treatment of human cystic and alveolar echinococcosis: Compounds and therapeutic targets. PLoS Negl Trop Dis 2018;12:e0006422. [PMID: 29677189 DOI: 10.1371/journal.pntd.0006422] [Cited by in Crossref: 56] [Cited by in F6Publishing: 61] [Article Influence: 11.2] [Reference Citation Analysis]
7 Impact of Intestinal Efflux Transporters on Oral Absorption. Oral Bioavailability Assessment 2017. [DOI: 10.1002/9781118916926.ch6] [Reference Citation Analysis]
8 Ito N, Ito K, Ikebuchi Y, Toyoda Y, Takada T, Hisaka A, Oka A, Suzuki H. Prediction of Drug Transfer into Milk Considering Breast Cancer Resistance Protein (BCRP)-Mediated Transport. Pharm Res 2015;32:2527-37. [PMID: 25690342 DOI: 10.1007/s11095-015-1641-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
9 Stuurman FE, Nuijen B, Beijnen JH, Schellens JH. Oral anticancer drugs: mechanisms of low bioavailability and strategies for improvement. Clin Pharmacokinet 2013;52:399-414. [PMID: 23420518 DOI: 10.1007/s40262-013-0040-2] [Cited by in Crossref: 77] [Cited by in F6Publishing: 66] [Article Influence: 7.7] [Reference Citation Analysis]
10 Bircsak KM, Richardson JR, Aleksunes LM. Inhibition of human MDR1 and BCRP transporter ATPase activity by organochlorine and pyrethroid insecticides. J Biochem Mol Toxicol 2013;27:157-64. [PMID: 23169446 DOI: 10.1002/jbt.21458] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]